• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖相关的肝脏并发症。

Hepatic complications of obesity.

机构信息

Department of Medicine, Division of Gastroenterology, Duke University, Durham, NC 27710, USA.

出版信息

Gastroenterol Clin North Am. 2010 Mar;39(1):57-68. doi: 10.1016/j.gtc.2009.12.001.

DOI:10.1016/j.gtc.2009.12.001
PMID:20202579
Abstract

Obesity is associated with a spectrum of chronic liver disease. Because obesity increases the risk for advanced forms of liver disease (ie, cirrhosis and liver cancer), the obesity epidemic is emerging as a major factor underlying the burden of liver disease in the United States and many other countries. This article reviews mechanisms that mediate the pathogenesis of obesity-related liver disease, summarizes clinical evidence that demonstrates obesity-related liver disease can be life-threatening, and discusses whether or not treatments for obesity or related comorbidities impact liver disease outcomes.

摘要

肥胖与一系列慢性肝病有关。由于肥胖会增加晚期肝病(即肝硬化和肝癌)的风险,因此肥胖流行正在成为美国和许多其他国家肝病负担的主要因素。本文综述了介导肥胖相关肝病发病机制的机制,总结了表明肥胖相关肝病可能危及生命的临床证据,并讨论了治疗肥胖或相关合并症是否会影响肝病结局。

相似文献

1
Hepatic complications of obesity.肥胖相关的肝脏并发症。
Gastroenterol Clin North Am. 2010 Mar;39(1):57-68. doi: 10.1016/j.gtc.2009.12.001.
2
Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.脂肪酸在肥胖和脂肪肝发病机制中的作用:减肥手术的影响
Semin Liver Dis. 2008 Nov;28(4):407-26. doi: 10.1055/s-0028-1091985. Epub 2008 Oct 27.
3
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
4
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.综述文章:维罗纳糖尿病研究中的2型糖尿病与慢性肝病
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:24-7. doi: 10.1111/j.1365-2036.2005.02590.x.
5
Impact of diabetes on the severity of liver disease.糖尿病对肝脏疾病严重程度的影响。
Am J Med. 2007 Oct;120(10):829-34. doi: 10.1016/j.amjmed.2007.03.025.
6
Nonalcoholic fatty liver disease in individuals with severe obesity.严重肥胖个体中的非酒精性脂肪性肝病
Clin Liver Dis. 2004 Aug;8(3):535-47, viii. doi: 10.1016/j.cld.2004.04.007.
7
Effects of weight loss on nonalcoholic fatty liver disease.体重减轻对非酒精性脂肪性肝病的影响。
Semin Liver Dis. 2008 Nov;28(4):427-33. doi: 10.1055/s-0028-1091986. Epub 2008 Oct 27.
8
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.病态肥胖患者非酒精性脂肪性肝炎和肝纤维化进展的预测因素
Obes Surg. 2005 Mar;15(3):310-5. doi: 10.1381/0960892053576820.
9
[Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].[非酒精性脂肪性肝炎:诊断、发病机制、治疗与预后]
Ned Tijdschr Geneeskd. 2005 Feb 5;149(6):289-94.
10
Hepatic histology in obese patients undergoing bariatric surgery.接受减肥手术的肥胖患者的肝脏组织学。
J Hepatol. 2006 Oct;45(4):600-6. doi: 10.1016/j.jhep.2006.06.013. Epub 2006 Jul 25.

引用本文的文献

1
Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways.免疫细胞在肝细胞癌疾病及相关通路中的作用
ACS Pharmacol Transl Sci. 2023 Nov 8;6(12):1801-1816. doi: 10.1021/acsptsci.3c00216. eCollection 2023 Dec 8.
2
Role of adipose tissue macrophages in obesity-related disorders.脂肪组织巨噬细胞在肥胖相关疾病中的作用。
J Exp Med. 2022 Jul 4;219(7). doi: 10.1084/jem.20211948. Epub 2022 May 11.
3
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.脂肪组织和脂肪因子与肥胖相关性肝癌发展的相关性。
Int J Mol Sci. 2021 Feb 22;22(4):2163. doi: 10.3390/ijms22042163.
4
The Protective Effects of Danggui-Baizhu-Tang on High-Fat Diet-Induced Obesity in Mice by Activating Thermogenesis.当归白术汤通过激活产热对高脂饮食诱导的小鼠肥胖的保护作用
Front Pharmacol. 2018 Sep 5;9:1019. doi: 10.3389/fphar.2018.01019. eCollection 2018.
5
Peroxisome Proliferator-Activated Receptor Gamma in Obesity and Colorectal Cancer: the Role of Epigenetics.过氧化物酶体增殖物激活受体 γ 在肥胖与结直肠癌中的作用:表观遗传学视角。
Sci Rep. 2017 Sep 6;7(1):10714. doi: 10.1038/s41598-017-11180-6.
6
TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.内皮型一氧化氮合酶的瞬时受体电位香草酸亚型4激活通过阻断细胞色素P450 2E1介导的氧化还原毒性来抵抗非酒精性脂肪性肝病。
Free Radic Biol Med. 2017 Jan;102:260-273. doi: 10.1016/j.freeradbiomed.2016.11.047. Epub 2016 Nov 29.
7
Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?肥胖会增加慢性乙型肝炎患者患肝细胞癌的风险吗?
Clin Mol Hepatol. 2016 Sep;22(3):336-338. doi: 10.3350/cmh.2016.0104. Epub 2016 Sep 25.
8
Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.使用药物和营养保健品对肥胖相关肝癌发生进行化学预防。
World J Gastroenterol. 2016 Jan 7;22(1):394-406. doi: 10.3748/wjg.v22.i1.394.
9
Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.嘌呤能受体X7介导非酒精性脂肪性肝炎中星状细胞内瘦素诱导的葡萄糖转运蛋白4功能。
Biochim Biophys Acta. 2016 Jan;1862(1):32-45. doi: 10.1016/j.bbadis.2015.10.009. Epub 2015 Oct 22.
10
Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.新加坡华人健康研究中的膳食脂肪酸与肝细胞癌风险
Liver Int. 2016 Jun;36(6):893-901. doi: 10.1111/liv.12978. Epub 2015 Oct 27.